New Therapies for MASH: What Healthcare Teams Need to Know

A common liver disease is quietly affecting millions of Americans. Are we doing enough to catch it early? In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Sara Klockars, PharmD, explores the growing prevalence of MASLD and MASH. She reviews newly approved treatment options, including semaglutide and resmetirom, and discusses how healthcare teams can help identify, support, and manage patients throughout their care journey. This is an excerpt from our April 2026 Pharmac...